Media

BIO Digital is the world's largest virtual biotech partnering and education event, convening thousands of global biotech leaders and innovators. Join us in our efforts to accelerate a BIO-Revolution through global

About ASCO Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer. Join us at

AACR ANNUAL MEETING 2022 Decoding Cancer Complexity | Integrating Science | Transforming Patient Outcomes The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians,

Join us at The World Vaccine Congress this year in Washington, DC.  It is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one

-Data from preclinical studies demonstrates that UNITE, as a nucleic acid platform, elicits potent immune responses in mice- November 02, 2020 08:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics,

Oct. 22, 2020 12:00 UTC Immunomic Therapeutics Announces Promotion of Dr. Tim Coleman to Senior Vice President, Operations and General Manager ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. (ITI), a privately-held

October 20, 2020 08:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI) announced today that it will be presenting at the 5th International Virtual Conference on Cancer Research &

10 International Vaccine Influencers Who Exemplify Maryland’s Leading Role in Public Health Immunomic Therapeutics is listed as one of the Top 10 Maryland Vaccine Influencers in public health and Dr.

September 29, 2020 08:00 AM Eastern Daylight Time   ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. announced today that it will participate in a panel at the MD Life Sciences Bio Innovation

September 23, 2020 08:00 AM Eastern Daylight Time   ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. announced today that it will be participating in Precision Medicine’s webinar on utilizing liquid biopsy to

Cancer R&D 2020 Symposium ITI is proud to be participating in the 5th International Conference on Cancer Research and Drug Development 2020, a three-day symposium bringing cutting edge developments in

ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. (ITI) announced today that it will participate at the World Vaccine Congress Washington being held virtually September 28-October 1, 2020. Andrew Eisen, MD, Ph.D.,